APS could dose-dependently promote the hematopoietic (EPO, G-CSF, and IL-3) and immunomodulatory (TNF-α) factors in mice of a hemodepletion model to return to normal levels. This evidence concerns the gene CSF3 and autoimmune polyendocrinopathy.